← Eichor
Study identifier: NCT06907901 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Reliability of PHAS in Postural Hyperkyphosis

Condition: Postural Kyphosis · Spine · Assessment, Self  ·  Sponsor: Istanbul University - Cerrahpasa

PhaseN/A
Planned participants128
Who can joinAll sexes, 8 Years to 65 Years
Healthy volunteersNo

About this study

This observational, cross-sectional study aims to evaluate the reliability of the Postural Habits and Awareness Scale (PHAS) in patients with postural hyperkyphosis. The PHAS is designed to assess individuals' postural awareness and habits through four subscales. A total of 128 participants diagnosed with postural hyperkyphosis will complete the PHAS and the Kyphosis-Specific Spinal Appearance Questionnaire (KSSA). Test-retest reliability will be assessed by reapplying the PHAS after two weeks. Internal consistency, test-retest reliability, and concurrent validity will be analyzed. The study aims to provide a valid and reliable tool for evaluating postural awareness in clinical practice and future rehabilitation studies.

This description comes directly from the study's public registry record.

Talk to the study team

Kübra Kardeş, PhD  ·  905387115631  ·  kubra.koce@istinye.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Istanbul University-CerrahpasaIstanbul, Istanbul, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06907901